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Abstract— This research article reports the synthesis of a 
series of 4-methyl-2-(p-substitutedphenyl)quinoline 
derivatives which display potent antifungal activities. 
Moreover the potency of the synthesized compounds have 
been explored by means of Quantitative Structure Activity 
Relationship(QSAR) study carried out using regression 
analysis and statistically significant (r2) QSAR models.  A 
number of descriptors were tested to adjudge a 
quantitative correlation between activity and structural 
features using training set and test set. It is evident from 
the QSAR study that majority of the antifungal activity is 
due to lipophilicity as well as cLogP influence on the 
biological activity. The results were interpreted on the 
basis of regression analysis. Since the developed QSAR 
models are found to be statistically significant and 
predictive, they can potentially be used for prediction of 
antifungal activities of new molecules before 
prioritization of their synthesis  
Keywords— Quinoline derivatives, Descriptors, QSAR, 
Model validation, Antifungal activity, Regression 
analysis. 
 
I. INTRODUCTION 
Drug development is a cumbersome process which 
involve huge amount of investment in terms of money 
and time. It is estimated that it takes millions of dollars 
and around 15 years to transform a single potent molecule 
into effective drug. QSAR offers an alternative path to 
this process which offers quick and economical method of 
development of drug. QSAR has emerged as latest tool to 
design newer candidate for several therapeutic areas[1-
3].QSAR provides useful insights into the structural 
features which are responsible for biological activity and  
helps to generate a mathematical model which can predict 
activity of untested compounds quantitatively. These 
structurally related activities are commonly referred as 
structure-active relationship (SAR)[4]. The mathematical 
and statistical analysis of QSAR data finally help to 
reduce the number of molecules with the potent biological 
activity testing. QSAR study usually leads to predictive 
formula by correlation of physicochemical properties of a 
congeneric series with the biological activity[5]. Agrawal 
et al. [6-15] have reported QSAR studies on different 
organic drug compounds. In the present investigation, 
QSAR study of a series of quinoline derivatives has been 
carried out to find out their antifungal potency. The study 
includes 8 descriptors which have been selected to 
develop the best fit model. The generated QSAR model 
was then used to predict the unknown antifungal activity 
of the test set compounds. 
 
II. EXPERIMENTAL 
All chemicals/reagents used throughout the investigation 
were of AR/chemically pure grade. Number of quinoline 
derivative were synthesised in accordance with the 
scheme represented in the Fig.1. The structures of the 
derivatives were confirmed with the help of techniques 
like 1H NMR, IR and Mass spectroscopy. The synthesised 
quinoline derivatives were used as test set for the 
calculation of the antifungal activity. The details of the 
formulation of synthesised compounds are given in Table 
1.
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Table 1. Synthesised Test Set Quinoline compounds with their yield and Melting point 
Sr. No. Compound R Molecular formula Yield (%) M.P. (°C) 
1.  A H C16H13N 79 177-179 
2.  B CH3 C17H15N 74 183-185 
3.  c OCH3 C17H15NO 73 224-227 
4.  d OH C16H13NO 77 288-290 
5.  e NO2 C16H12N2O2 72 237-239 
6.  f Cl C16H12ClN 86 218-221 
7.  g Br C16H12BrN 87 248-252 
8.  h COOH C17H13NO2 76 360-362 
 
QSAR studies  
Generation of Training Data Set 
In the present investigation, a series of substituted quinoline based compounds reported by Sandhya Bawa et al.[16] and B. C. 
Revanasiddapppa et al.[17] were selected as training set.  Total of 30 molecules with different substitution on the quinoline 
scaffold were selected as training set with their known biological activity with certain fungi. Structures of all the compounds 
determined by 2D-QSAR analysis and the antifungal activities in form of Zone of Inhibition (mm) have been presented in the 
Table 2 and 3. Structures of all compounds were sketched by chemdraw 8.0 software (chemoffice)[18].   
N Cl
NNH
BHHA
HX
R1
R2
R
1-10
Fig. 2: Training  data set molecues from 1-10
 
 
Table.2: Composition and biological activity of training data set molecules from 1-10 
Comp. no. R R1/R2 ZOI (mm) 
   A. niger C. albicans 
1 H Cl 11.53 - 
2 6-CH3 Cl 10.69 - 
3 7-CH3 Cl 12.16 - 
4 8-CH3 Cl 10.58 - 
5 6-OCH3 Cl 11.03 - 
6 H OCH3 9.16 - 
7 6-CH3 OCH3 7.86 - 
8 7-CH3 OCH3 8.66 - 
9 8-CH3 OCH3 7.63 - 
10 6-OCH3 OCH3 6.83 - 
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Table.3: Composition and biological activity of training  data set molecules from 11-30 
Comp. 
no. 
R-CHO ZOI (mm) Comp. 
No. 
R-COCH3 ZOI (mm) 
  A. niger C. albicans   A. niger C. albicans 
11 C6H5 11 9 21 C6H5 10 11 
12 p-Cl 10 8 22 p-Cl 11 11 
13 p-OCH3 10 10 23 p-OCH3 12 10 
14 p-CH3 9 11 24 p-CH3 10 9 
15 p-(CH3)2N 11 10 25 m-NO2 9 8 
16 o-Cl 10 10 26 p-NO2 8 7 
17 m-Br 10 9 27 p-NH2 9 7 
18 p-OH 09 10 28 p-Br 10 10 
19 m-OH 11 11 29 p-OH 11 11 
20 p-Br 10 10 30 o-OH 10 11 
 
 
Descriptor Calculation 
Various physicochemical descriptors like constitutional, molecular, steric, and electronic were calculated by the 
Datawarrier[19] Software . The descriptors used to develop the model are listed and described in the Table 4. 
Table 4: Descriptors used for the training and test set 
S. No. Descriptor used Symbol 
1 Total Molweight in g/mol; natural abundance TMW 
2 cLogP; P; conc(octanol) /conc(water) cLogP 
3 Total surface area(from polar and non-polar SAS Approximation) TSA 
4 Druglikeness Drug 
5 Lipophilic Ligand Efficiancy (LLE) LLE 
6 Ligand Efficiency Lipophilic Price(LELP) LELP 
7 Molecular shape Index MSI 
8 Rotatable Bond Count RBC 
 
The descriptors calculated for the compounds and are given in the Table 5. 
Table 5. The value of descriptors calculated for the training set 
S. no. TMW cLogP TSA Drug LLE LELP MSI RBC 
1 376.673 5.3854 259.83 1.8974 3.6146 10.468 0.58333 2 
2 390.7 5.7293 272.09 1.8 2.9697 12.002 0.56 2 
3 390.7 5.7293 272.09 1.8 2.7936 12.25 0.6 2 
4 390.7 5.7293 272.09 1.8 2.6686 12.432 0.56 2 
5 406.699 5.3154 282.09 1.7961 2.9856 12.136 0.57692 3 
6 367.835 4.0334 273.51 1.7961 4.1884 9.2973 0.57692 4 
7 381.862 4.3773 285.77 1.7352 3.7776 10.564 0.55556 4 
8 381.862 4.3773 285.77 1.7352 3.7196 10.64 0.59259 4 
N
OCH2CONHN=CH R11-20
N
OCH2CONHN=C
CH3
R
21-30
Fig. 3: Training data set molecules form 11-30
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9 381.862 4.3773 285.77 1.7352 3.6685 10.707 0.55556 4 
10 397.861 3.9634 295.77 1.7961 4.0366 10.112 0.57143 5 
11 305.336 3.0925 244.11 4.1966 4.8661 6.5145 0.65217 5 
12 339.781 3.6985 259.53 4.2278 4.2223 8.1687 0.66667 5 
13 335.362 3.0225 266.37 4.2013 4.8636 6.9844 0.68 6 
14 319.363 3.4364 256.37 4.1258 4.4175 7.6545 0.66667 5 
15 348.405 2.9889 278.93 4.9362 4.835 7.2401 0.65385 6 
16 339.781 3.6985 259.53 4.2278 4.0974 8.2996 0.625 5 
17 384.232 3.8177 262.74 2.4066 3.9519 8.5961 0.625 5 
18 321.335 2.7468 250.46 4.1816 4.9979 6.2046 0.66667 5 
19 321.335 2.7468 250.46 4.1816 4.9744 6.2235 0.625 5 
20 384.232 3.8177 262.74 2.4066 3.8813 8.6749 0.66667 5 
21 319.363 3.0304 254.58 3.1347 4.6474 6.9049 0.625 5 
22 353.808 3.6364 270 3.1884 4.0212 8.6537 0.64 5 
23 349.389 2.9604 276.84 3.1842 4.6779 7.3453 0.65385 6 
24 333.39 3.3743 266.84 3.1347 4.2455 8.0698 0.64 5 
25 364.36 2.1088 278.25 -1.944 5.4933 5.4595 0.59259 6 
26 364.36 2.1088 278.25 -1.944 5.4762 5.4717 0.62963 6 
27 334.378 2.3531 263.1 3.1166 5.2155 5.6656 0.64 5 
28 398.259 3.7556 273.21 1.3447 3.7972 9.0613 0.64 5 
29 335.362 2.6847 260.93 3.143 4.8529 6.4906 0.64 5 
30 335.362 2.6847 260.93 3.143 4.8382 6.5033 0.6 5 
  
Regression Analysis 
The linear regression was performed using the software SPSS[20] by stepwise method. The best model derived from the 
regression analysis was used to predict the biological activity of the synthesised compounds. No outliers have been 
determined and the equations were derived using the entire training data set (n=30). The summary of the model generated is 
given in the Table 6. 
Table.6: Summary of the QSAR model generated by the regression analysis 
Model Summary 
Model R R Square Adjusted R Square Std. Error of the Estimate Durbin-
Watson 
1 0.762 0.580 0.420 0.9830729 2.296 
Predictors: (Constant), Rotatable_Bonds, Total_Surface_Area, Druglikeness, Shape_Index, Total_Molweight, 
LLE, cLogP, LELP 
Dependent Variable: Reported activity 
 
Validation test 
It has been proved that a high value of statistical characteristic ‘r2’ and ‘F’ and low value of ‘s’ need not be the criteria for a 
highly predictive model. Hence the models were converted in the form of equation by using the generated correlation values. 
The equations, then, were used to calculate the unknown activities of the test set compounds. The equations 1 and 2 are 
generated by the model. The comparison between the predicted and the experimental biological activities are graphically 
represented in Fig. 4. 
 
QSAR model for A. Niger 
Biological activity (ZOI)  = (18.354) + (-0.007* TMW) + (4.359*cLogP) + ( 0.132* TSA) + (0.315*Drug) + (2.963*MSI) + 
(-0.419*RBC)----------- (1) 
QSAR model for C. Albicans 
Biological activity (ZOI) = (18.354) + (-0.007* TMW) + (4.359*cLogP) + ( 0.132*TSA) + (0.315*Drug) + (2.963* MSI) + 
(-0.419*RBC)------------- (2) 
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Fig. 4: Predicted and Experimental biological activities of test set quinoline compounds 
 
In-vitro antimicrobial activity 
The in-vitro antibacterial activity of the 2,4-substituted quinoline derivatives was investigated against two strains of fungi. 
Nutrient agar media was employed for the fungal growth.  Fungal  plates were incubated at 280C for 5-7 days. Two microbial 
strains i.e. A. niger and C. albicans were used in antimicrobial assay. Griseofulvin was used as standard. All the synthesised 
compounds were tested for their antifungal potency as compared to the reference drug within MIC range of 25-50μg/ml. The 
screening results have been tabulated in the Table 7. 
Table.7: Antifungal screening of the synthesised quinoline derivatives 
Compound 
Diameter of zone of inhibition (mm) 
A. niger C. albicans 
Predicted Experimental Predicted Experimental 
a. 58.87 57 58.87 57 
b. 61.96 60 61.96 60 
c. 61.06 60 61.06 60 
d. 58.17 58 58.17 58 
e. 55.62 56 55.62 56 
f. 63.43 60 63.43 60 
g. 63.44 60 63.44 60 
h. 59.21 60 59.21 60 
Griseofulvin 65 62 
 
III. RESULT AND DISCUSSION 
In the present study, eight descriptors were selected for 
the prediction of antifungal activity. The synthesised 
quinoline derivatives have been found to possess very 
good antifungal activity.  The predicted and the 
experimental activities are in good agreement with each 
other. QSAR studies performed on these compounds have 
revealed that descriptors used to generate the model 
correlates the structure with the biological activity 
significantly.  
 
IV. CONCLUSION 
Conclusively a series of 2,4-substituted quinoline 
derivatives have been synthesised and proved as potential 
antibacterial agents. The synthesised compounds have 
shown remarkable anti biological activity as confirmed 
from their high coefficient values.  It can also be observed 
that the compounds bearing electron donating groups (b, 
c, f, g and h) have found to possess little enhanced 
antifungal activity.  The self developed QSAR models 
were found to be statistically significant as suggested 
from their regression analysis. Thus investigations 
presented in the research paper may have potential 
practical applicability in light of drug 
designing/pharmology.  
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